Avecho Biotechnology Ltd (AVE) — Cash Flow Reinvestment Rate
Avecho Biotechnology Ltd (AVE) has a Cash Flow Reinvestment Rate of 0.00x as of June 2025, reinvesting AU$0.00 (capex AU$0.00 ) from operating cash flow of AU$2.27 Million. Check AVE cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Avecho Biotechnology Ltd Cash Flow Reinvestment Rate (1993–2025)
Historical reinvestment intensity for Avecho Biotechnology Ltd across 3 annual periods. Explore Avecho Biotechnology Ltd debt service capacity to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Avecho Biotechnology Ltd (1993–2025)
Year-by-year capital reinvestment analysis for Avecho Biotechnology Ltd. For live market cap and broader valuation context, see market value of Avecho Biotechnology Ltd.
| Year | Reinvestment Rate | Total Reinvested (AUD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.00x | AU$0.00 | AU$1.10 Million | AU$0.00 | ▼ -100.0% |
| 2019 | 0.01x | AU$16.21K | AU$1.19 Million | AU$5.15K | — |
| 1993 | 0.00x | AU$0.00 | AU$23.00K | AU$0.00 | — |